Inventor · disambiguated record
Graeme Freestone
Also filed as: FREESTONE GRAEME · FREESTONE GRAEME C
8 granted patents·6 pending applications·8 citations·filing 2011–2024
80Inventor score
Files withDART NEUROSCIENCE CAYMAN LTD7IONIS PHARMACEUTICALS INC4DART NEUROSCIENCE LLC2GUPTA VARSHA1
Top patents by PatentIndex Score
14 records- 0188US9932345B2Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2015·Granted Apr 3, 2018·3 cites·35 claims
- 0285US2025092047A1Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 0378US11186582B2Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2019·Granted Nov 30, 2021·0 cites·20 claims
- 0477US2023192698A1Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Application pending·0 cites
- 0576US9150572B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted Oct 6, 2015·2 cites·3 claims
- 0676US9102674B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted Aug 11, 2015·2 cites·35 claims
- 0772US9675605B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Jun 13, 2017·1 cites·7 claims
- 0861US10501465B2Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Granted Dec 10, 2019·0 cites·22 claims
- 0961US2023095696A1Oligomeric compounds comprising backbone constrained macrocyclesIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1059US9956213B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2017·Granted May 1, 2018·0 cites·18 claims
- 1159US2025154506A1Linkage modified oligomeric compounds and uses thereofIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1252US2023159922A1Modified oligomeric compounds and uses thereofIONIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1351US2022064636A1Modified oligomeric compounds and uses thereofIONIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1435US9012470B2Therapeutic 5,6,5-tricyclic analogsGUPTA VARSHA·Filed 2011·Granted Apr 21, 2015·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Graeme Freestone files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →